Welcome to our dedicated page for Koninklijke Phil news (Ticker: PHG), a resource for investors and traders seeking the latest updates and insights on Koninklijke Phil stock.
Royal Philips (Koninklijke Philips N.V., NYSE: PHG) is a health technology company whose news flow centers on diagnostic imaging, ultrasound, image-guided therapy, monitoring, enterprise informatics and personal health. Company announcements frequently highlight AI-enabled systems, new product launches and strategic portfolio moves, giving investors and observers insight into how Philips develops and positions its health technology offerings.
Recent Philips news has featured AI-powered innovations in image-guided therapy and diagnostic imaging, such as LumiGuide 3D Device Guidance for light-based navigation during minimally invasive procedures, DeviceGuide for AI-assisted tracking of heart valve repair devices, and Verida, a detector-based spectral CT system with AI integrated across the imaging chain. The company also reports advances in MRI through its BlueSeal Horizon 3.0T platform and extended partnerships in neuroimaging, such as the integration of Cortechs.ai quantitative analytics into Philips MR workflows.
News items also cover enterprise informatics and cloud-based solutions, including the launch of Philips Management 15, a web-based diagnostic viewer that delivers full radiology capabilities through a browser and interfaces with AI tools and interactive reporting. In addition, Philips communicates on long-term partnerships with health systems, monitoring agreements and large-scale deployments of its Azurion image-guided therapy systems.
Corporate and portfolio developments appear regularly in the news stream. Examples include the agreement to acquire SpectraWAVE Inc. to expand intravascular imaging and physiology solutions, and the completed carve-out of the Philips Emergency Care business, which now operates as Heartstream under a Philips brand license. Earnings-related releases and Form 6-K summaries provide context on comparable order intake, sales trends, margins, productivity programs and outlook.
Investors and healthcare professionals following PHG news can use this page to track product introductions, AI and imaging milestones, strategic transactions and quarterly performance updates that shape Philips’ role in global health technology.
Masimo (NASDAQ: MASI) has announced a significant multi-year renewal and expansion of its strategic partnership with Royal Philips (NYSE: PHG) through 2026 and beyond. The expanded collaboration will accelerate the integration of Masimo's monitoring technologies, including SET® pulse oximetry, into Philips' multi-parameter patient monitors.
The partnership includes integration of Radius PPG® with Masimo-board equipped Philips monitors and the development of next-generation wearable solutions. The companies will jointly develop and promote AI-based monitoring technologies. Additional Masimo technologies available on Philips devices include SpHb®, O3® regional oximetry, SedLine® brain function monitoring, and NomoLine® capnography.
Philips (NYSE:PHG) has partnered with Philips Foundation and nonprofit MedShare International to launch an innovative disaster preparedness program in the United States. The initiative focuses on pre-positioning medical equipment for rapid deployment during natural disasters, featuring advanced ultrasound systems and mother-and-child care products.
The program, prompted by Hurricane Helene in 2024, aims to ensure healthcare continuity during emergencies. Philips North America is contributing ultrasound systems for cardiac, vascular, and obstetric imaging, supported by field service engineers. The two-year pilot program includes a sustainable approach where equipment will be reprocessed and redeployed after each emergency.
This partnership addresses a critical need, as the U.S. has faced nearly 400 climate disasters causing over $1 billion in damages each over the past 45 years.
Philips (NYSE:PHG) has unveiled a new smart telemetry platform featuring the next-generation Telemetry Monitor 5500 for enhanced cardiac monitoring. The platform addresses critical healthcare challenges including staff shortages and alarm management, where hospitals face an average of 350 alarms per patient per day.
The innovative solution integrates with Philips' central monitoring unit (CMU) to provide simplified workflows, scalable monitoring capabilities, and data-driven insights. Key features include a compact wearable monitor with touchscreen interface, tools to filter non-actionable alarms, and connected bedside coordination through the Care Assist mobile application.
Additionally, Philips offers Mobile Cardiac Telemetry (MCOT) technology for monitoring cardiac patients up to 30 days post-discharge, enabling continuous care transition and remote patient monitoring.
Philips (NYSE:PHG) has unveiled Transcend Plus, a significant upgrade to its EPIQ CVx and Affiniti CVx cardiovascular ultrasound systems. The new platform features FDA-cleared enhancements in 2D and 3D imaging quality and 26 AI-enabled clinical applications - the highest number in the industry.
Key innovations include the new 2D Auto EF Advanced feature, which expands AI capabilities for contrast images, and improved visualization tools for cardiac anatomy and function. The system is designed to help cardiology teams manage increasing patient volumes and clinical complexity while maintaining diagnostic accuracy, particularly in left ventricular function assessment.
Transcend Plus will be showcased at the European Society of Cardiology 2025 Congress and the American Society of Echocardiography annual meeting.
Philips (NYSE: PHG) has launched its new Head Shaver Pro Series, expanding its electric shaving portfolio with advanced features for head grooming. The series, priced between $79.99-$139.99, introduces innovative technologies including PowerAdapt Sensor, 360-degree Flexing Head, and 36 ComfortCut blades.
The launch addresses a significant market opportunity, targeting the 70+ million U.S. men experiencing balding, with nearly half actively shaving their heads. Key features include 90-minute runtime, quick charging capabilities, waterproof design, and a specialized hair collection system. Replacement heads are available at $34.99 and come with a recommendation for six-month replacement cycles.
[ "Targets large addressable market of 70+ million U.S. men experiencing balding", "Premium pricing strategy with $79.99-$139.99 range suggests healthy margins", "Recurring revenue potential through $34.99 replacement heads every 6 months", "Extended 5-year warranty offering builds customer confidence and brand loyalty" ]Philips (NYSE:PHG) has launched its Lumea IPL hair removal device in the United States market. As the global #1 IPL brand, Philips brings 25 years of research experience to home hair removal technology. The device promises salon-like results with 90% hair reduction in three sessions, requiring touch-ups only every four weeks.
The Philips Lumea IPL features SenseIQ Technology for personalized treatment and comes with four attachments for different body areas. The product is available exclusively on Amazon at prices ranging from $399.99 to $579.99, including a five-year warranty with registration. The device has been tested by over 3,000 consumers and is currently used by more than 6 million people globally.
Philips (NYSE:PHG) has announced plans to invest over $150 million in U.S. manufacturing and R&D facilities, building upon its existing annual R&D investment of $900 million in the country. The expansion includes the Reedsville, PA facility for AI-enabled ultrasound systems and the Image Guided Therapy facility in Plymouth, MN.
The Reedsville expansion will add 24,000 square feet of manufacturing space and 40,000 square feet of warehouse space, creating 120 skilled manufacturing jobs. The facility will customize software and configurations for specific clinical procedures. The Plymouth facility expansion includes a new medtech training center and is expected to create over 150 new jobs.
Philips currently serves 90% of U.S. hospitals and employs nearly 17,000 people across 40 facilities in the United States.
Philips (NYSE: PHG) has secured landmark agreements with Indonesia's Ministry of Health to deploy advanced Azurion image-guided therapy systems across all 38 provinces. This nationwide initiative, part of the Strengthening Indonesia's Healthcare Referral Network (SIHREN) project, aims to transform treatment for heart disease, stroke, and cancer through minimally invasive care.
The project addresses healthcare accessibility challenges in Indonesia, the world's fourth most populous nation with over 280 million people spread across 17,000+ islands. The initiative comes as Indonesia faces rising non-communicable diseases projected to cost USD 4.47 trillion. Philips, employing over 3,900 people across 12 Indonesian cities, won the contract through an international competitive bidding process.
Philips (NYSE:PHG) reported strong Q2 2025 performance with 6% comparable order intake growth and sales of EUR 4.3 billion, representing a 1% comparable sales increase. The company's Adjusted EBITA margin expanded by 130 basis points to 12.4%, while free cash flow improved to EUR 230 million.
Key segment performance showed mixed results: Diagnosis & Treatment and Connected Care saw 1% sales decreases but margin improvements, while Personal Health achieved 6% comparable sales growth. The company secured significant partnerships, including a nationwide agreement with Indonesia's Ministry of Health, and received FDA clearance for its AI-powered SmartSpeed Precise MR software.
Philips increased its full-year 2025 outlook, raising its Adjusted EBITA margin range to 11.3%-11.8% and free cash flow forecast to EUR 0.2-0.4 billion, while maintaining its 1-3% comparable sales growth guidance.
Philips (NYSE: PHG) has announced a strategic collaboration with Epic to integrate its cardiac ambulatory monitoring and diagnostics services with Epic's Aura specialty diagnostics platform. This integration will create the largest cardiac care portfolio available through Epic's Aura platform to date.
The collaboration aims to enhance interoperability between Philips' monitoring technologies and Epic's systems, allowing healthcare providers to order and review ECG results directly within Epic. Key benefits include automated patient activation, staff notifications, and charting, significantly reducing manual data entry and streamlining workflow efficiencies for cardiac care teams.